<DOC>
	<DOCNO>NCT00895349</DOCNO>
	<brief_summary>The purpose trial improve clinical management outcome patient locally advanced cervical cancer use positron emission tomography-computed tomography ( PET-CT ) imaging . There considerable debate worldwide regard utility PET stag cervical cancer . Although study accuracy ( sensitivity specificity ) PET cervical cancer , currently prospective randomize study PET information affect treatment decision outcome .</brief_summary>
	<brief_title>Impact Positron Emission Tomography ( PET ) Imaging Women With Locally Advanced Cervical Cancer ( PET LACE Trial )</brief_title>
	<detailed_description>Cervical cancer second common cause cancer death worldwide . In Canada , estimate 2009 1,300 new case cervical cancer 380 woman die disease . The corresponding 2009 data Ontario 500 new case 140 death . In Canada , cervical cancer screen Pap test allow diagnosis curative treatment precancerous lesion cervix early cervical cancer . Symptoms cervical cancer include vaginal bleeding discharge . Unfortunately often associate advanced disease . The cost associate health care increase . PET expensive imaging modality . Given resource health care unlimited , need high quality evidence intervention PET 's efficacy .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Adenosquamous</mesh_term>
	<criteria>Women newly diagnose histologically confirm FIGO Stage IBIVA carcinoma cervix , include squamous , adenosquamous adenocarcinoma . Women suitable surgery due comorbidities ( medical condition ) also consider eligible . Age equal great 18 year Being consider treatment curative intent use concurrent chemotherapy pelvic RT . ECOG performance status great 2 . Other cervical cancer tumour type ( e.g . neuroendocrine , serous ) . Carcinoma cervical stump . Prior hysterectomy . Patients , time initial evaluation , already undergone whole body PETCT within last 6 month . Contraindications 18FDG PETCT CT abdomen pelvis . Inability lie supine imaging PETCT . Contraindication radiotherapy ( i.e. , significant Crohn 's disease ) . Contraindication cisplatin chemotherapy ( i.e. , nonreversible renal failure ) . Inadequate bone marrow function : ANC le 1.5 X 10^9 , platelet le 100 X 10^9 . Inadequate renal function : Creatinine greater/equal 150 micromol/L Inadequate hepatic function : Bilirubin great 1.5 X ULN SGOT Alkaline Phosphatase great 3 X ULN . History another invasive malignancy within previous 5 year exception nonmelanoma skin cancer . Other medical condition may preclude chemoradiation therapy . Known pregnancy lactate . Inability complete study require followup .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Positron Emission Tomography ( PET )</keyword>
	<keyword>Diagnostic Intervention</keyword>
	<keyword>Locally Advanced Cervical Cancer</keyword>
</DOC>